01-06-2013 | Erratum
Erratum to: Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder
Application of a Matching-Adjusted Indirect Comparison
Published in: Applied Health Economics and Health Policy | Issue 3/2013
Login to get access